Respiratory syncytial virus (RSV) was first identified in 1957 and was quickly recognized as a common and important cause of respiratory tract infection in infants and young children (1, 2) . More recently, however, RSV has been found to be a relatively frequent cause of both upper and lower respiratory tract disease in the elderly, resulting in substantial morbidity and mortality.
Virology
Respiratory syncytial virus, a member of the Paramyxoviridae family, is an enveloped RNA virus with a genome that encodes for ten distinct mRNAs, each of which directs translation of a single viral protein (3) . Of the eight structural proteins, two envelope glycoproteins, F and G, are most important in early viral replication and as protective antigens (4) . The larger G (attachment) protein serves to adsorb to host cells, while the F (fusion) protein promotes fusion of the viral and cell membranes (4) . Neutralizing epitopes are present on both proteins, and F is also recog- nized as a target in cell-mediated immunity (4) . The recent application of monoclonal antibody and genetic technology to antigenic analysis, especially to the G protein, has permitted recognition of two viral groups, A and B (5) (6) (7) (8) . Restriction fragment analysis has identified even greater diversity within groups (9-11). Antigenic variation among RSV isolates may contribute to the ability of RSV to cause disease in hosts despite the presence of specific antibodies (9) .
Epidemiology
Respiratory syncytial virus epidemics generally occur at regular, predictable, yearly intervals, although RSV seasons vary in different parts of the world (4, (12) (13) (14) (15) . In Rochester, New York, USA, RSV outbreaks usually start in October and end in April, generally peaking in January (16) . The occurrence of different RSV groups in the same outbreak is common, although one subtype generally predominates (17, 18) . While another study from Rochester (19) reported that greater severity of RSV disease in infants was associated with group A virus, other studies noted no difference in severity of illnesses caused by the two groups (10, 17) . There is no information regarding RSV group and clinical disease characteristics in the elderly.
Respiratory syncytial virus is the most common cause of lower respiratory tract infections in infants and children throughout the world (1, 16, (20) (21) (22) . Primary infection is often associated with significant morbidity, particularly in infants younger than 6 months of age, or with underlying cardiopulmonary disease, as well as in infants from lower socioeconomic groups in both industrial and developing countries (23, 24) . Infection rates are unrelated to either race or sex, although illness is more severe in male infants (12, 13) . Reinfection with RSV is common, and older children and adults are not immune (25) (26) (27) . Children previously infected with a virus of one group appear to be somewhat less susceptible to repeat infections with a virus of the same group, perhaps due to residual antibodies specific to the G protein (28) .
Transmission
The virus is transmitted either directly or indirectly through large droplets via fomites and direct contact with secretions (29, 30) . Target cells for the virus are the ciliary epithelium cells in the respiratory tract (31) . Ward personnel probably play a central role in introducing and spreading the virus. During RSV epidemics in elderly residents of long-term care facilities, an overall attack rate of 40% has been reported, which is similar to attack rates in household contacts of infected children (32) (33) (34) . The incubation period for RSV disease is three to five days (13) . Lower respiratory tract infection symptoms usually appear one to three days after the onset of rhinorrhea by spreading via respiratory epithelium or through aspirated secretions (4). The virus shedding phase is shorter in adults than in children (1.6 vs. 3.9 days) (34) , and the titer of the virus is lower in adults (J. A. Englund et al., 34th ICAAC, Orlando, 1994, Abstract no. H3C).
Clinical Manifestations in the Elderly
Asymptomatic infections are rare, even in reinfections (12, 25, 35) . Respiratory syncytial virus reinfections in adults have not been considered serious, since they generally result in mild disease (36) . Nevertheless, in adults, as in children, the infection has been reported to cause altered airway resistance and exacerbation of chronic obstructive lung disease (37, 38) . In the elderly, however, RSV pneumonia has been described (37, 39) . In persons over 60 years of age, RSV usually causes mild nasal congestion, but can also result in fever, anorexia, pneumonia, bronchitis, and even death (32, 33, 36, 37, (40) (41) (42) (43) (44) (45) . Respiratory mucosa is often dry in older patients, even when it is infected, and the mucus is more viscous in the etderly than in children (46) . The age of patients appears to play a crucial role and predisposes to more serious disease due to age-related changes in lung function, underlying medical conditions, or a deteriorating immune system. Several studies have shown age-related morphologic changes in the respiratory tracts and in the mechanics of respiration in the elderly (47, 48) . Among institutionalized elderly people in Rochester, New York, RSV caused 25% of respiratory illnesses, followed by rhinovirus (9 %), parainfluenza virus (6%), and influenza virus (1%) (49) . Respiratory syncytial virus and influenza virus infections are clinically indistinguishable and often circulate simultaneously (41, 49) . A study during four winter seasons in Birmingham, UK, suggested that RSV is as important as influenza virus in causing morbidity and excess deaths among the elderly (50) . A recent study of communitydwelling elderly showed that 10% of hospitalized patients with respiratory illness in the winter had RSV infection and 11% had influenza A, with death rates of 10% and 6%, respectively (51).
Immunology of Respiratory Syncytial Virus Reinfection
The role of immunoglobulins in RSV reinfection is controversial. Some experimental studies in adults have shown that reinfection with RSV is independent of the level of serum antibodies but dependent on the level of locally secreted antibodies (52) . However, challenge studies of young adults by Hall et al. (53) showed that serum antibodies to F and G proteins correlated with protection. Serum RSV-specific immunoglobulin G (IgG) is present at relatively high levels in RSVinfected elderly patients, peaking between 11 and 30 days after the onset of illness (36) . Eighty-five percent of RSV culture-positive elderly patients have a greater than fourfold rise in RSV-specific IgG (40) . Interestingly, patients with bronchopneumonia had higher initial IgG titers in comparison to those with milder illness (40) . There is no information available on the role of cellmediated immune functions and RSV reinfection.
Diagnosis
Diagnosis of RSV infection in the elderly is difficult. In infants, the use of standard cell culture methods is generally slow, and, therefore, rapid immunochemical techniques for direct detection of the virus (immunofluorescence and enzyme immunoassay) are often used (54, 55) . Due to a shorter shedding phase and dry mucosa in the elderly, these tests are less effective in adults than in children. Because of difficulty with cooperation among the elderly, nasopharyngeal swabs are usually obtained instead of nasopharyngeal secretions or nasal washes. This specimen type is not optimal for either culture or rapid antigen testing. In the elderly, culture is only 50% sensitive compared with retrospective serological detection of specific IgG antibodies by enzyme immunoassay (40, 56 ). An alternative, rapid, and direct viral diagnostic method to be used on nasopharyngeal secretions has recently been introduced. The method is based on reverse transcription and amplification of viral nucleic acid sequences by the polymerase chain reaction, and has a sensitivity of 94.6% and a specificity of more than 97% in infants (9, (57) (58) (59) (60) (61) . This method has already been shown to offer advantages in other difficult-to-diagnose viral infections, such as those caused by hepatitis C virus (62, 63) , human immunodeficiency virus (64) , and rhinovirus (65) . Its use for diagnosing RSV infection in the elderly has not been evaluated.
Serologic diagnosis in the elderly using IgM assay has been reported, although studies regarding its utility are conflicting. This method is based on the finding that reinfections with RSV at an interval of one year have been shown to result in an accelerated IgM response (66) . In one study, the authors reported that 81 To of the elderly have specific IgM antibodies (67) . In about 70% of patients, the diagnosis was confirmed in a single serum sampie about one week after the onset of symptoms (67) . However, in another study specific IgM antibody responses occurred in only 11.5% of elderly patients (36) . As these were reinfections, IgM might be expected to be less frequent than in the young. Specific IgM in adults, as in children, seldom appears in serum before day 5 of disease, and generally not before day 7 (67). Thus, this method is not particularly helpful in the diagnosis of RSV in the elderly during acute illness.
Prevention and Therapy
Attempts to prevent RSV infection by vaccination have not been successful, in part because the pathogenesis and immune responses to the infection are not well understood. In infants, ribavirin aerosol treatment (20 mg/ml) of RSV bronchiolitis has been reported to result in a significantly more rapid improvement than that in a control group (68) . There are no controlled trials of ribavirin therapy in the elderly. However, anecdotal reports in immunocompromised adults and elderly adults suggest that it may be beneficial in selected cases (69, 70) . Nevertheless, continuous aerosol ribavirin treatment for 12 to 18 hours a day in agitated or confused elderly patients is difficult. Use of high-dose (60 mg/ml) ribavirin for 6 hours a day may provide a more practical approach (71) .
Administration of high titered RSV-specific immunoglobulin in the elderly in the early phase of RSV disease may be beneficial, but it has never been tested. Regardless, therapy in the elderly is dependent upon a method that will increase the possibility of diagnosing the virus in this age group. In addition, distinguishing RSV from influenza infection is important, since it may reduce unnecessary use of amantadine prophylaxis or therapy, thereby avoiding toxic side effects. Finally, rapid accurate diagnosis allows avoidance of unnecessary antibiotics.
